BAULIEU, Étienne-Émile
|
Effet d’un stéroide anti-progestérone chez la femme: Interruption du cycle menstruel et de la grossesse au début.Compt. Rend. l'Acad. Sci., Sér. III, 294, 933–8, 1982."In April 1980, as part of a formal research project at the French pharmaceutical company Roussel-Uclaf for the development of glucocorticoid receptor antagonists, chemist Georges Teutsch synthesized mifepristone (RU-38486, the 38,486th compound synthesized by Roussel-Uclaf from 1949 to 1980; shortened to RU-486), which was discovered to also be a progesterone receptor antagonist.[54][55] In October 1981, endocrinologist Étienne-Émile Baulieu, a consultant to Roussel-Uclaf, arranged tests of its use for medical abortion in 11 women in Switzerland by gynecologist Walter Herrmann at the University of Geneva's Cantonal Hospital, with successful results announced on April 19, 1982" (Wikipedia article on Mifepristone, accessed 4-2020). Subjects: OBSTETRICS & GYNECOLOGY › OBSTETRICS › Abortion, PHARMACOLOGY › PHARMACEUTICALS › Abortion |
|
Génération pilule.Paris: Editions Odile Jacob, 1990.Translated into English as The "abortion pill": RU-486 - a woman's choice by Étienne-Émile Baulieu with Mort Rosenblum. New York: Simon & Schuster, 1991. Subjects: OBSTETRICS & GYNECOLOGY › OBSTETRICS › Abortion, PHARMACOLOGY › PHARMACEUTICALS |